EVALUATION OF EFFICACY OF BUSERELIN-DEPO IN PATIENTS WITH LOCALLY ADVANCED AND METHASTATIC PROSTATE CANCER

Our surveillance was performed for 358 patients with locally advanced and disseminated prostate gland cancer who were treated by analogues of LHRH. Patients in group 1 (n = 222) received treatment with a LHRH analogue, and patients in group 2 (n = 136) received treatment with 75 mg Buserelin-depo 3....

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: S. V. MISHUGIN, A. A. DROBYAZKO, A. A. MORDOVIN, A. A. GRICKEVICH, I. G. RUSAKOV
Materialtyp: Artigo
Språk:Russo
Publicerad: Remedium Group LLC 2017-06-01
Serie:Медицинский совет
Ämnen:
prostate cancer
hormone therapy
agonists of luteinizing hormone releasing hormone
buserelin
prostate-specific antigen
testosterone
Länkar:https://www.med-sovet.pro/jour/article/view/1893
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk